SIEN Sientra Inc

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the company will be participating in the upcoming SVB Leerink 10th Annual Global Healthcare Conference. Sientra’s management team is scheduled to present on Friday, February 26, 2021 at 3:40 p.m. ET.

Event: SVB Leerink 10th Annual Global Healthcare ConferenceDate: Friday, February 26, 2021Time: 3:40 p.m. ET                           An audio webcast of the Company’s presentation will be made available on the investor relations section of Sientra’s website at http://www.sientra.com. A replay will be available for 90 days.

About SientraHeadquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com. (*) Data on file

ContactInvestor Relations805-679-8885